Vera Therapeutics Cash Flow Statement
NASDAQ: VERAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
29.88+0.15 (+0.50%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vera Therapeutics free cash flow
In fiscal 2025, Vera Therapeutics generated -$241.1 million of operating cash flow and spent $630,000 on capital expenditures. That left free cash flow of -$241.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Vera Therapeutics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Net Income | -299.62M | -152.15M | -95.99M | -89.06M | -32.61M | -53.41M |
| Net Income growth (YoY) | — | — | — | — | — | — |
| Depreciation & Amortization | 468.00K | 105.00K | 21.00K | -846.00K | 176.00K | 251.00K |
| Stock-Based Compensation | 37.93M | 20.80M | 11.49M | 8.89M | 3.01M | 331.00K |
| Change in Working Capital | 24.42M | 4.72M | -2.92M | 9.46M | 3.56M | 542.00K |
| Operating Cash Flow | -241.10M | -134.68M | -92.18M | -67.60M | -23.71M | -34.81M |
| Capital Expenditures | -630.00K | -972.00K | -63.00K | -62.00K | 0 | -99.00K |
| Investing Cash Flow | 194.29M | -425.03M | -39.43M | -70.55M | -4.20M | -42.00K |
| Share Repurchases | 0 | -13.00K | 0 | — | — | — |
| Financing Cash Flow | 308.90M | 606.67M | 133.54M | 101.93M | 53.88M | 85.29M |
| Net Change in Cash | 262.08M | 46.97M | 1.93M | -36.22M | 25.97M | 50.44M |
| Free Cash Flow | -241.73M | -135.65M | -92.24M | -67.66M | -23.71M | -34.91M |
This table shows 6 annual periods of Vera Therapeutics's cash flow statement, from FY 2025 back to FY 2020, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow VERA's reporting calendar. What is a cash flow statement?